Allegan, Inc.
Records under this name other than patents Allegan, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Allegan, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,691,566 | Cells useful for immuno-based botulinum toxin serotype a activity assays Lapsed on the fee record Ended Apr 8, 2026 · USPTO record | Lapsed on the fee record | Ended Apr 8, 2026 | USPTO record |
| US 7,217,725 | Prostaglandin D2 antagonist Term ended Term ended Feb 9, 2021 · USPTO record | Term ended | Term ended Feb 9, 2021 | USPTO record |
| US 6,956,057 | EP4 agonists as agents for lowering intraocular pressure Lapsed on the fee record Ended Oct 18, 2017 · USPTO record | Lapsed on the fee record | Ended Oct 18, 2017 | USPTO record |
| US 5,320,806 | Methods to disinfect contact lenses Term ended Term ended no later than Jun 14, 2014 · Low confidence | Term ended | Term ended no later than Jun 14, 2014 | Low confidence |
| US 5,338,480 | Compositions and methods to clean contact lenses Term ended Term ended no later than Aug 16, 2014 · Low confidence | Term ended | Term ended no later than Aug 16, 2014 | Low confidence |
| US 5,803,925 | IOL insertion apparatus with covalently bonded lubricant Formerly held Term ended Term ended no later than Sep 8, 2018 · Low confidence | Term ended | Term ended no later than Sep 8, 2018 | Low confidence |